SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001395064-21-000181
Filing Date
2021-08-30
Accepted
2021-08-30 06:07:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga-083021.htm SC 13G/A 114764
2 EX-99.1 exhibit991_083021.htm EX-99.1 1889
3 EX-99.2 exhibit992_083021.htm EX-99.2 15659
  Complete submission text file 0001395064-21-000181.txt   133846
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Subject) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90985 | Film No.: 211220801
SIC: 2834 Pharmaceutical Preparations